DTC
AUTL

Deep Track Capital’s Autolus Therapeutics AUTL Stock Holding History

Deep Track Capital’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,568,613
Closed -$4.19M – 58
2025
Q3 		$4.19M Sell
2,568,613
-14,283,534
-85% -$27.9M 0.12% 50
2025
Q2 		$38.4M Sell
16,852,147
-997,335
-6% -$1.65M 1.23% 27
2025
Q1 		$27.7M Buy
17,849,482
+3,630,579
+26% +$7.37M 0.9% 30
2024
Q4 		$33.4M Sell
14,218,903
-1,053,269
-7% -$3.56M 1.25% 27
2024
Q3 		$55.4M Hold
15,272,172
– – 1.76% 21
2024
Q2 		$53.1M Hold
15,272,172
– – 1.59% 25
2024
Q1 		$97.4M Buy
15,272,172
+3,402,875
+29% +$21.2M 2.79% 15
2023
Q4 		$76.4M Sell
11,869,297
-3,130,703
-21% -$11.9M 2.55% 12
2023
Q3 		$35M Hold
15,000,000
– – 1.35% 27
2023
Q2 		$35.7M Hold
15,000,000
– – 1.65% 19
2023
Q1 		$27.6M Hold
15,000,000
– – 1.13% 28
2022
Q4 		$28.5M Buy
+15,000,000
New +$37.9M 1.2% 30
2022
Q2 		– Sell
-382,559
Closed -$1.59M – 53
2022
Q1 		$1.59M Buy
+382,559
New +$1.61M 0.1% 51

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Deep Track Capital's AUTL Position: Q4 2025 in Review

Deep Track Capital sold out of Autolus Therapeutics (AUTL) in Q4 2025, closing a stake of 2,568,613 shares — an estimated $4.19M sold.

Deep Track Capital first reported a position in AUTL in Q1 2022 and held it in 13 quarters. The position peaked at $97.4M in Q1 2024. 89 funds tracked by Wall St. Rank hold AUTL as of Q4 2025.

  • Deep Track Capital reported no remaining Autolus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Deep Track Capital sold 2,568,613 Autolus Therapeutics shares in Q4 2025, an estimated $4.19M.
  • Deep Track Capital first reported a position in Autolus Therapeutics in Q1 2022 and held it in 13 quarters.
  • Deep Track Capital's Autolus Therapeutics position peaked at $97.4M in Q1 2024.
  • 89 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q4 2025.

Based on Deep Track Capital's 13F filing for Q4 2025, filed 13 Feb 2026.